Christina Pohlman: Could aPL Levels Help Predict Stroke Recurrence?
Christina Pohlman, CEO and Co-Founder of APS Foundation of America, shared a post on LinkedIn about a recent article by Macy L E Gatti et al., published in RPTH, adding:
“Could the level of persistent antiphospholipid antibodies help tell us more about stroke recurrence?
A new study followed 47 people who had experienced a cryptogenic stroke or TIA and continued to test positive for antiphospholipid antibodies (aPLs) for at least 12 weeks.
Researchers found that recurrent ischaemic stroke was less common in people with weakly positive aPLs than in those with strongly positive aPLs.
Treatment patterns also differed: antiplatelet medicines were recommended more often in the weakly positive group, while warfarin was more commonly recommended for those with strongly positive aPLs.
It’s an interesting finding, but the study was small, retrospective and carried out within one health system.
The researchers say larger prospective studies and randomized trials are needed to better understand the best treatment approach.”
Title: Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies
Authors: Macy L E Gatti, Steven R Messé, Adam Cuker

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?